1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > Akers Biosciences, Inc. (AKR) - Medical Equipment - Deals and Alliances Profile

Summary

Akers Biosciences, Inc. (ABI) is a medical device company that develops, manufactures and supplies rapid, point-of-care screening and testing products. The company offers products such as BreathScan, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA Chlamydia, PIFA Dengue Fever, PIFA Malaria, PIFA Syphilis, PIFA Heparin, and breath ketone. It provides testing platform technologies that include MPC biosensor, particle immunofiltration assay, rapid enzymatic assay, minDNA, and synthetic macrocycle complex. The company also offers seraSTAT rapid blood cell separation, a sample preparation technology. ABI is headquartered in West Deptford, New Jersey, the US.

Akers Biosciences, Inc. (AKR) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Akers Biosciences, Inc. (AKR) - Medical Equipment - Deals and Alliances Profile
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Akers Biosciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Akers Biosciences, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
Akers Biosciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Akers Biosciences, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 9
Akers Biosciences, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Akers Biosciences, Inc., Medical Equipment, Deal Details 11
Asset Purchase 11
Akers Biosciences Acquires Technology Assets From Pulse Health 11
Partnerships 12
Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management 12
Akers Biosciences Enters into Distribution Agreement with Medline Industries 13
Akers Biosciences Enters into Distribution Agreement with Typenex 14
Equity Offering 15
Akers Biosciences Completes Public Offering Of Shares For US$15 Million 15
Akers Biosciences Completes Private Placement Of US$3.2 Million 17
Akers Biosciences, Inc. - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations and Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 18, 2015: Akers Biosciences Announces Q2 2015 Earnings 21
May 14, 2015: Akers Biosciences Announces Financial Results for First Quarter 2015 25
Mar 23, 2015: Akers Biosciences Reports Earnings for Fiscal Year 2014 26
Corporate Communications 28
Nov 23, 2015: Akers Biosciences Appoints Medical Technology Specialist as CEO 28
Nov 12, 2015: Akers Biosciences Appoints Dr. Raza Bokhari as Non-executive Director 29
Jun 30, 2015: Akers Biosciences Appoints Former Congressman Rob Andrews to the Board 30
Jan 20, 2015: Akers Expands U.S. Sales Efforts with Key Leadership Additions 31
Legal and Regulatory 32
Feb 09, 2015: Akers Management System Certified to ISO 13485 (2003) 32
Product News 33
Nov 04, 2015: Akers Biosciences' Flagship Test for Heparin-Induced Thrombocytopenia Granted Approval by Chinese Food and Drug Administration 33
Apr 13, 2015: Akers Biosciences Further Expands International Distribution Of Flagship Rapid Test 34
Product Approvals 35
Nov 04, 2015: Akers Biosciences' Flagship Test for Heparin-Induced Thrombocytopenia Granted Approval by Chinese Food and Drug Administration 35
Other Significant Developments 36
Nov 13, 2015: Akers Biosciences Announces Q3 2015 Earnings 36
Apr 02, 2015: Akers Bio Signs Distribution Agreement With ADS for U.S. Govt. 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Akers Biosciences, Inc., Medical Equipment, Key Facts, 2014 1
Akers Biosciences, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Akers Biosciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Akers Biosciences, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
Akers Biosciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Akers Biosciences, Inc., Deals By Market, 2010 to YTD 2016 9
Akers Biosciences, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Akers Biosciences Acquires Technology Assets From Pulse Health 11
Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management 12
Akers Biosciences Enters into Distribution Agreement with Medline Industries 13
Akers Biosciences Enters into Distribution Agreement with Typenex 14
Akers Biosciences Completes Public Offering Of Shares For US$15 Million 15
Akers Biosciences Completes Private Placement Of US$3.2 Million 17
Akers Biosciences, Inc., Key Competitors 18
Akers Biosciences, Inc., Key Employees 19
Akers Biosciences, Inc., Subsidiaries 20

List of Figures
Akers Biosciences, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Akers Biosciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Akers Biosciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Akers Biosciences, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Akers Biosciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Akers Biosciences, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 7
Akers Biosciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Akers Biosciences, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 9

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
3D Cell Culture Technologies Patent Landscape

3D Cell Culture Technologies Patent Landscape

  • $ 5489
  • Company report
  • September 2016
  • by KnowMade

IP landscape for 3D cell culture technologies offers an important space to big entities as well as for small companies 3D CELL CULTURE : REPRODUCING AN IN VIVO-LIKE ENVIRONMENT IN VITRO The patent landscape ...

Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016

Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glucose Dependent Insulinotropic Receptor (G Protein ...

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2016

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Plasminogen Activator Inhibitor 1 (Endothelial ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.